Literature DB >> 8188380

Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major.

I Müller1, P Kropf, J A Louis, G Milon.   

Abstract

Reinfection of immune mice with Leishmania major elicits a secondary gamma interferon (IFN-gamma) response to which specific CD8+ T cells are essential. We have shown previously that specific CD8+ T cells from reinfected immune mice release substantially higher levels of IFN-gamma, a cytokine essential for the efficient activation of parasitized macrophages to kill intracellular L. major. By using an ELISPOT assay, which allows the detection of IFN-gamma production by individual cells, it is shown here that this elevated IFN-gamma response is the result of an increase of up to 50-fold in the frequency of parasite-specific CD8+ T lymphocytes in the spleens and draining lymph nodes of both immune reinfected CBA and BALB/c mice. This observation is additional evidence of the role that CD8+ T cells play in immunity to reinfection with L. major.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188380      PMCID: PMC186547          DOI: 10.1128/iai.62.6.2575-2581.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Recognition of protozoan parasite antigens by murine T lymphocytes. I. Induction of specific T lymphocyte-dependent proliferative response to Leishmania tropica.

Authors:  J Louis; E Moedder; R Behin; H Engers
Journal:  Eur J Immunol       Date:  1979-11       Impact factor: 5.532

2.  On the control between cell-mediated, IgM and IgG immunity.

Authors:  P A Bretscher
Journal:  Cell Immunol       Date:  1974-08       Impact factor: 4.868

3.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

4.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

5.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Significance and mechanisms of cellular regulation of the immune response.

Authors:  P A Bretscher
Journal:  Fed Proc       Date:  1981-04

7.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

8.  Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: analysis by flow microfluorometry.

Authors:  H R MacDonald; R K Lees; B Sordat; P Zaech; J L Maryanski; C Bron
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

9.  Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight.

Authors:  M Pierres; C Goridis; P Golstein
Journal:  Eur J Immunol       Date:  1982-01       Impact factor: 5.532

10.  Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells.

Authors:  I Müller; P Kropf; R J Etges; J A Louis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more
  29 in total

1.  Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis.

Authors:  A Kariminia; E Bourreau; H Pascalis; P Couppié; D Sainte-Marie; F Tacchini-Cottier; P Launois
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Memory T cells in cutaneous leishmaniasis.

Authors:  Nelson D Glennie; Phillip Scott
Journal:  Cell Immunol       Date:  2016-07-16       Impact factor: 4.868

3.  CD8+ T Cells Lack Local Signals To Produce IFN-γ in the Skin during Leishmania Infection.

Authors:  Fernanda O Novais; Andrea C Wong; Daniel O Villareal; Daniel P Beiting; Phillip Scott
Journal:  J Immunol       Date:  2018-01-24       Impact factor: 5.422

4.  Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.

Authors:  I S Leal; B Smedegârd; P Andersen; R Appelberg
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.

Authors:  Sylvie Bertholet; Alain Debrabant; Farhat Afrin; Elisabeth Caler; Susana Mendez; Khaled S Tabbara; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.

Authors:  S Farajnia; F Mahboudi; S Ajdari; N E Reiner; A Kariminia; M H Alimohammadian
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

7.  Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine.

Authors:  I S Leal; M Flórido; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

8.  Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice.

Authors:  Nathan C Peters; Sylvie Bertholet; Phillip G Lawyer; Melanie Charmoy; Audrey Romano; Flavia L Ribeiro-Gomes; Lisa W Stamper; David L Sacks
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

9.  Optimized subunit vaccine protects against experimental leishmaniasis.

Authors:  Sylvie Bertholet; Yasuyuki Goto; Lauren Carter; Ajay Bhatia; Randall F Howard; Darrick Carter; Rhea N Coler; Thomas S Vedvick; Steven G Reed
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

Review 10.  Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance.

Authors:  Kordula Kautz-Neu; Kirsten Schwonberg; Michael R Fischer; Anja I Schermann; Esther von Stebut
Journal:  Med Microbiol Immunol       Date:  2012-09-16       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.